
IonQ (IONQ) has just lined up two high profile hardware deployments, including a Superion 256-qubit system for Florida International University and an on-premise Superion 256 at the NVIDIA Accelerated Quantum Research Center.
IonQ’s recent contracts with NVIDIA and Florida International University arrive after a mixed price pattern, with a 9.54% 1 month share price return but a decline of 7.44% year to date and a 1 year total shareholder return down 45.36%, while the 5 year total shareholder return of about 4x shows how sentiment around the long term story has already swung sharply in the past.
Look beyond IonQ and identify additional quantum and AI infrastructure opportunities that align with your thesis using our curated 24 quantum computing stocks.
IonQ now carries fresh commercial wins and a sharply reset share price. Do you lean into this reset today, or wait for a cleaner entry once the valuation work is done?
IonQ’s most followed narrative anchors fair value at $48 per share against a last close of $43.29, which implies modest upside in the eyes of that framework while still asking investors to underwrite a complex, high-spend quantum story.
The biggest risk is still valuation. IonQ’s stock price now implies that the company is very likely to remain one of the long-term winners in quantum. That may happen, but it is not yet proven. A premium multiple on a strong company is one thing; a valuation that leaves almost no room for disappointment is another.
See why 90 investors see IonQ as 10% undervalued.
Result: Fair Value of $48 (UNDERVALUED)
Still, IonQ’s premium price and ongoing losses mean any stumble in quantum adoption or delays in major contracts could quickly pressure that 9.8% upside narrative.
Find out about the key risks to this IonQ narrative.
Sentiment around IonQ is clearly split, which makes this a moment where speed matters less than clarity. Before you react, take time to weigh both sides of the thesis using the 1 key reward and 3 important warning signs.
If IonQ has sharpened your thinking, do not stop there. Use the Simply Wall Street Screener to pressure test your thesis across different types of opportunities.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com